CATB - Catabasis Pharmaceuticals Stock Trading

Catabasis Pharmaceuticals Inc.(NASDAQ: CATB) stock trading, description, contact, officers and directors.

About Catabasis Pharmaceuticals Inc.

Not available

Stock Information

Catabasis Pharmaceuticals Inc. Company Name:

CATB Stock Symbol:

NASDAQ Market:

CATB - Catabasis Pharmaceuticals Stock Trading

Get CATB Alerts

News, Short Squeeze, Breakout and More Instantly...

CATB - Catabasis Pharmaceuticals Presents Information on Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy, at the Virtual 25th International Congress of the World Muscle Society

-- New Preclinical Research Indicates that Edasalonexent Could Have Positive Effects on Cardiac Function and Preserve Bone Health -- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today shared information on the edasalonexent p...
CATB - Catabasis Pharmaceuticals to Present During the Virtual 25th International Congress of the World Muscle Society

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present information on the edasalonexent program, in Phase 3 development for the treatment of Duchenne muscular dystrophy (DMD), during the 25 th International...
CATB - Catabasis Pharmaceuticals Names Noah Clauser Chief Financial Officer

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, announced today that it has promoted Noah Clauser to Chief Financial Officer. Mr. Clauser brings close to 20 years of financial experience to this role and has been with Catabasis for 9 years,...